[Indomethacin retard 75 mg in the treatment of coxarthrosis].
A single dose of 75 mg Sustained-Release Indomethacin proved to be an effective medication in the treatment of osteoarthritis of the hip. It was generally well tolerated; two patients reported moderate gastrointestinal side effects, no CNS related side effects. The gastric tolerance appeared to be better than with Amuno. The convenience of the single dose therapy was spontaneously expressed by all patients.
D000328:Adult; D000368:Aged; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D005260:Female; D006621:Hip Joint; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D004304:Dosage Forms; D007213:Indomethacin
Indometacin retard 75 mg bei der Behandlung der Koxarthrose.